Alcon Inc (CHIX:ALCz)
CHF 70.04 -0.72 (-1.02%) Market Cap: 34.49 Bil Enterprise Value: 37.51 Bil PE Ratio: 35.48 PB Ratio: 1.79 GF Score: 63/100

Q3 2024 Alcon AG Earnings Call Transcript

Nov 13, 2024 / 01:00PM GMT
Release Date Price: CHF77.24 (+0.65%)

Key Points

Positve
  • Alcon Inc (ALC) reported a solid quarter with sales of $2.4 billion, reflecting a 6% growth.
  • Core diluted earnings per share increased by 25% to $0.81, with a core operating margin of 20.6%.
  • The company generated a record $1.3 billion in free cash flow in the first nine months of the year.
  • Alcon Inc (ALC) is preparing for a series of product launches, including Precision7 contact lenses and Systane Pro Preservative Free eye drops, which are expected to drive future growth.
  • The international uptake of advanced technology intraocular lenses (AT-IOLs) is strong, with high single-digit or double-digit growth in most regions.
Negative
  • Alcon Inc (ALC) experienced slower market conditions in the United States, impacting implantable sales.
  • The company had to adjust its full-year revenue guidance due to softness in the US surgical market.
  • There is competitive pressure in the US market, with new products from competitors affecting sales.
  • The company faces challenges in maintaining its market share in the US IOL market due to competitive sampling.
  • Alcon Inc (ALC) expects normal seasonal pressure on gross margins in the fourth quarter due to annual preventative maintenance at its plants.
Operator

Greetings, and welcome to the Alcon third-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Dan Cravens, Vice President, Investor Relations. Thank you, sir. You may begin.

Dan Cravens
Alcon AG - Vice President - Investor Relations

Welcome to Alcon's third-quarter 2024 earnings conference call. Yesterday, Alcon was alerted that our third quarter earnings press release and interim financial report were inadvertently posted early to our investor website. We immediately accelerated our disclosure process. The NYSE briefly halted trading pending the issuance of the release. Trading was resumed on the NYSE shortly after the release crossed the newswire.

In addition, earlier today, we also posted a supplemental slide presentation on our website to enhance today's call. You can find all of these documents in the Investor Relations section of our website at alcon.com. Joining me on today's call are David Endicott, our Chief Executive Officer; and Tim

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot